ARID4B and leukemia: Contrary, in human leukemias, ARID4B seems to exert a tumor suppressor activity, and either its downregulation or heterozygous inactivating mutations alongside mutations in ARID4A in vivo lead to leukemic transformation through indirect epigenetic mechanisms [18].